Salmeterol/fluticasone Diskus

DRUG2 trials

Sponsors

AstraZeneca

Conditions

AsthmaChronic Obstructive Pulmonary Disease

Phase 3

Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg

CompletedNCT00242775

AstraZenecaAsthma

Start: 2005-05-31End: 2006-05-31Target: 2100Updated: 2011-01-24

Phase 4

Airway Clearance Study

CompletedNCT00379028

AstraZenecaChronic Obstructive Pulmonary Disease

Start: 2006-09-30End: 2007-07-31Updated: 2011-01-24

Related Papers

Direct healthcare cost comparison of Fluticasone propionate/Salmeterol vs Budesonide/Formoterol Maintenance And Reliever Therapy for moderate/severe asthma: Results from Thailand.

2025-03-01

Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam.

2021-03-274 citations

The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.

2009-10-3160 citations